Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective ACcrual To Investigate reprOductive Cancers in womeN

NCT06527157 is registered in ClinicalTrials.gov with PinkDx, Inc. as lead sponsor.

NCT NCT06527157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective ACcrual To Investigate reprOductive Cancers in womeN
Lead sponsor
PinkDx, Inc.
Phase
Observational
Overall status
Recruiting
Start date
July 30, 2024
Completion date
November 15, 2031
Enrollment
4,500 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

uterine cancer